SoftOx Solutions’ distributor, Bonaventura Scandza, has signed an agreement with NorgesGruppen for the sale of SafeDеs alcohol-free hand disinfectant, as is stated in a stock exchange announcement.
A new treatment for COVID-19, developed by Danish researchers, has just passed a test in animals.
The treatment is based on inhalation of particles that kill viruses and bacteria. The researchers behind it hope to be able to start the first safety tests in humans this spring.
SoftOx Solutions raised NOK 50 million in a private placement after the stock exchange closed on Wednesday this week.
According to an announcement from the company Friday, the interest was huge, and the issue of shares was more than 100 percent oversubscribed.